ストックスクリーナーアプリを入手
11.05
0.09%
-0.010
アフターアワーズ：
11.08
0.03
+0.27%
前日終値:
$11.06
開ける：
$11.61
24時間の取引高:
2.84M
Relative Volume:
1.33
時価総額：
$1.45B
収益：
$260.11M
当期純損益:
$60.64M
株価収益率:
25.70
EPS:
0.43
ネットキャッシュフロー:
$92.29M
1週間 パフォーマンス:
-15.00%
1か月 パフォーマンス:
-7.84%
6か月 パフォーマンス:
+33.29%
1年 パフォーマンス:
+50.75%
1日の値動き範囲:
$11.04
$11.65
1週間の範囲:
$10.34
$13.54
52週間の値動き範囲:
$6.55
$13.54
Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile
名前
Aurinia Pharmaceuticals Inc
セクター
電話
250-744-2487
住所
#140, 14315 - 118 AVENUE, EDMONTON, BC
AUPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AUPH
Aurinia Pharmaceuticals Inc
|
11.05 | 1.46B | 260.11M | 60.64M | 92.29M | 0.43 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-30 | 再開されました | H.C. Wainwright | Buy |
| 2022-11-04 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-05-05 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-12-10 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-10-28 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-01-25 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-11-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-17 | 開始されました | BTIG Research | Buy |
| 2020-05-05 | 開始されました | Cowen | Outperform |
| 2020-01-10 | 開始されました | Jefferies | Buy |
| 2019-12-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-03-16 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2018-02-08 | 開始されました | RBC Capital Mkts | Outperform |
| 2017-10-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-05-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-04-11 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-03-22 | 繰り返されました | FBR & Co. | Outperform |
| 2016-12-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-08-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-06-30 | 開始されました | H.C. Wainwright | Buy |
| 2015-05-08 | 開始されました | MLV & Co | Buy |
すべてを表示
Aurinia Pharmaceuticals Inc (AUPH) 最新ニュース
Aurinia Defends Benefit/Risk Profile of Lupus Nephritis Treatment After FDA Official's Retracted LinkedIn Post - MarketScreener
Aurinia Pharma rises after defending lupus drug - TradingView
Aurinia Sinks After FDA Official Questions Its Drug in Post - Bloomberg.com
Aurinia responds after top FDA official’s comment on lead drug - Seeking Alpha
Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery - MSN
Aurinia Pharmaceuticals stock hits 52-week high at 13.45 USD By Investing.com - Investing.com Nigeria
Aurinia Responds to Now Retracted LinkedIn Post - Business Wire
Why retail investors pile into Aurinia Pharmaceuticals Inc. stockWeekly Trade Analysis & Low Volatility Stock Recommendations - newser.com
Pharma company Aurinia falls after FDA official uses LinkedIn to call out lupus drug - Sherwood News
Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 52-Week HighHere's Why - MarketBeat
Aurinia drops after FDA official criticizes voclosporin - TipRanks
Aurinia Sinks After FDA Official Questions Its Drug on LinkedIn - Bloomberg.com
Pattern recognition hints at Aurinia Pharmaceuticals Inc. upside2025 Earnings Surprises & Fast Moving Market Watchlists - newser.com
Aurinia Pharmaceuticals stock hits 52-week high at 13.45 USD - Investing.com
Can swing trading help recover from Aurinia Pharmaceuticals Inc. lossesJuly 2025 Earnings & Reliable Trade Execution Plans - newser.com
How high can Aurinia Pharmaceuticals Inc. stock goMarket Growth Summary & AI Driven Stock Price Forecasts - newser.com
Analyzing net buyer seller activity in Aurinia Pharmaceuticals Inc.2025 Retail Activity & Reliable Volume Spike Trade Alerts - newser.com
Will Aurinia Pharmaceuticals Inc. price bounce be sustainableWeekly Trend Summary & Entry Point Confirmation Signals - newser.com
Using AI based signals to follow Aurinia Pharmaceuticals Inc.July 2025 Outlook & Daily Entry Point Alerts - newser.com
Is Aurinia Pharmaceuticals Inc a good long term investmentConsumer Goods Stocks & Build Wealth With Strategy - Early Times
Strs Ohio Buys New Shares in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Aurinia Pharmaceuticals Hits New 52-Week High of $13.44, Up 142% - Markets Mojo
Acropolis Investment Management LLC Invests $242,000 in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat
Aurinia Pharmaceuticals stock hits 52-week high at 13.12 USD By Investing.com - Investing.com Nigeria
Aurinia Pharmaceuticals Hits New 52-Week High of $13.05, Up 140.74% - Markets Mojo
Aurinia Pharmaceuticals stock hits 52-week high at 13.12 USD - Investing.com India
Aurinia Pharmaceuticals (NASDAQ:AUPH) Sets New 1-Year HighHere's What Happened - MarketBeat
Aurinia Pharmaceuticals stock climbs on insider buying - MSN
Does Aurinia Pharmaceuticals Inc. show high probability of reboundJuly 2025 Movers & AI Based Buy and Sell Signals - newser.com
Will Aurinia Pharmaceuticals Inc. outperform the marketGlobal Markets & Stepwise Trade Execution Plans - newser.com
Does Aurinia Pharmaceuticals Inc. fit your quant trading modelPortfolio Performance Summary & Short-Term High Return Ideas - newser.com
Aurinia’s Big Bet On Lupus Nephritis Is Paying Off - Finimize
26,155 Shares in Aurinia Pharmaceuticals Inc $AUPH Bought by City Center Advisors LLC - MarketBeat
Aug Sentiment: Why is Aurinia Pharmaceuticals Inc. stock going downMarket Performance Report & Weekly Top Performers Watchlists - خودرو بانک
Activity Recap: Is Aurinia Pharmaceuticals Inc stock a smart retirement pick2025 Price Momentum & Entry and Exit Point Strategies - خودرو بانک
Nephrotic Syndrome Market Analysis: Epidemiology Insights, Therapies, Companies, DelveInsight | GlaxoSmithKline, Goldfinch Bio, Inc., Travere Therapeutics, Inc., Aurinia Pharmaceuticals, Bristol-Myers - Barchart.com
Is now a turning point for Aurinia Pharmaceuticals Inc.Rate Hike & Verified Chart Pattern Signals - newser.com
Long term hold vs stop loss in Aurinia Pharmaceuticals Inc.Day Trade & Weekly Return Optimization Plans - newser.com
Aug Closing: Can Aurinia Pharmaceuticals Inc grow without external fundingShare Buyback & Expert Verified Stock Movement Alerts - khodrobank.com
Will a bounce in Aurinia Pharmaceuticals Inc. offer an exit2025 Market Sentiment & Weekly Watchlist for Hot Stocks - newser.com
What is the target price for Aurinia Pharmaceuticals Inc. stock2025 Winners & Losers & Technical Pattern Alert System - khodrobank.com
Aurinia stock jumps 14% on Q3 earnings, restructuring announcement - MSN
Aurinia Pharmaceuticals Inc. stock momentum explained2025 Retail Activity & Real-Time Price Movement Reports - newser.com
Aurinia Pharmaceuticals Hits New 52-Week High of $12.90 - Markets Mojo
Trading Recap: Is Aurinia Pharmaceuticals Inc. attractive at current valuation2025 Fundamental Recap & Intraday High Probability Setup Alerts - خودرو بانک
Market Moves: Will Aurinia Pharmaceuticals Inc. stock benefit from M&A2025 Technical Overview & Low Drawdown Momentum Ideas - khodrobank.com
Patterns Watch: What is the target price for Aurinia Pharmaceuticals Inc. stockQuarterly Trade Summary & AI Enhanced Execution Alerts - خودرو بانک
Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 1-Year HighStill a Buy? - MarketBeat
Aurinia Pharmaceuticals Inc (AUPH) 財務データ
収益
当期純利益
現金流量
EPS
Aurinia Pharmaceuticals Inc (AUPH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| TANG KEVIN | Director |
Aug 05 '25 |
Buy |
11.68 |
200,000 |
2,336,000 |
11,329,500 |
| TANG KEVIN | Director |
Aug 04 '25 |
Buy |
11.34 |
100,000 |
1,134,000 |
11,129,500 |
| Keenan Greg | Chief Medical Officer |
Aug 01 '25 |
Sale |
10.50 |
20,000 |
210,000 |
133,484 |
| Keenan Greg | Chief Medical Officer |
Mar 07 '25 |
Sale |
8.23 |
8,305 |
68,350 |
153,484 |
| Greenleaf Peter | Chief Executive Officer |
Mar 03 '25 |
Sale |
8.00 |
195,593 |
1,564,744 |
1,953,892 |
| Greenleaf Peter | Chief Executive Officer |
Mar 04 '25 |
Sale |
7.92 |
164,947 |
1,306,380 |
1,788,945 |
| Keenan Greg | Chief Medical Officer |
Mar 03 '25 |
Sale |
8.00 |
12,239 |
97,912 |
161,789 |
| Miller Joseph M | Chief Financial Officer |
Mar 03 '25 |
Sale |
8.00 |
61,859 |
494,872 |
633,515 |
| Miller Joseph M | Chief Financial Officer |
Mar 04 '25 |
Sale |
7.92 |
56,154 |
444,740 |
577,361 |
| Robertson Stephen P. | EVP, General Counsel |
Mar 03 '25 |
Sale |
8.00 |
64,872 |
518,976 |
566,883 |
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):